$13.14
-0.31-2.30%
At Close: -
$13.13
-0.0100-0.08%
After Hours: 1:00 PM EDT
15 minutes delayed
Enanta Pharma
ENTANASDAQ
Enanta Pharma (NASDAQ:ENTA) Stock, Earnings Estimates, EPS, And Revenue
Enanta Pharma reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 6
EPS
$-1.470
Quarterly Revenue
$17.1M
Annual Revenue
(as of Mar 31)
(as of Mar 31)
$72.9M
Analyze the earnings history of Enanta Pharma using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| ENTA | Enanta Pharma | -$1.86 | — | — | — | $18.89M | — | — | — | 08/05/2024 | Get Alert |
| ENTA | Enanta Pharma | -$1.79 | -$1.33 | -$1.47 | -10.53% | $17.80M | $16.52M | $17.05M | 3.23% | 05/06/2024 | Get Alert |
| ENTA | Enanta Pharma | -$1.39 | -$1.19 | -$1.58 | -32.77% | $23.59M | $21.28M | $18.00M | -15.40% | 02/07/2024 | Get Alert |
| ENTA | Enanta Pharma | -$1.27 | -$2.00 | -$1.33 | 33.50% | $20.32M | $17.50M | $18.93M | 8.20% | 11/20/2023 | Get Alert |
| ENTA | Enanta Pharma | -$1.53 | -$2.33 | -$1.86 | 20.17% | $19.48M | $18.06M | $18.89M | 4.61% | 08/07/2023 | Get Alert |
| ENTA | Enanta Pharma | -$1.63 | -$1.98 | -$1.79 | 9.60% | $18.72M | $19.18M | $17.80M | -7.22% | 05/08/2023 | Get Alert |
| ENTA | Enanta Pharma | -$1.48 | -$1.59 | -$1.39 | 12.58% | $27.65M | $22.57M | $23.59M | 4.50% | 02/07/2023 | Get Alert |
| ENTA | Enanta Pharma | -$1.22 | -$1.35 | -$1.27 | 5.93% | $23.57M | $22.86M | $20.32M | -11.12% | 11/21/2022 | Get Alert |
| ENTA | Enanta Pharma | -$1.19 | -$1.39 | -$1.53 | -10.07% | $21.62M | $20.70M | $19.48M | -5.90% | 08/08/2022 | Get Alert |
| ENTA | Enanta Pharma | -$1.09 | -$1.43 | -$1.63 | -13.99% | $20.13M | $20.67M | $18.72M | -9.45% | 05/09/2022 | Get Alert |
| ENTA | Enanta Pharma | -$0.41 | -$1.09 | -$1.48 | -35.78% | $31.74M | $27.44M | $27.65M | 0.76% | 02/08/2022 | Get Alert |
| ENTA | Enanta Pharma | -$1.46 | -$1.22 | -$1.22 | 0.00% | $23.63M | $26.34M | $23.57M | -10.50% | 11/22/2021 | Get Alert |
| ENTA | Enanta Pharma | -$0.71 | -$1.26 | -$1.19 | 5.56% | $18.65M | $22.14M | $21.62M | -2.33% | 08/05/2021 | Get Alert |
| ENTA | Enanta Pharma | -$0.30 | -$0.97 | -$1.09 | -12.37% | $27.62M | $24.85M | $20.13M | -18.99% | 05/06/2021 | Get Alert |
| ENTA | Enanta Pharma | $0.65 | -$0.74 | -$0.41 | 44.59% | $52.57M | $28.79M | $31.74M | 10.26% | 02/08/2021 | Get Alert |
| ENTA | Enanta Pharma | $0.44 | -$0.95 | -$1.46 | -53.68% | $51.31M | $25.74M | $23.63M | -8.19% | 11/23/2020 | Get Alert |
| ENTA | Enanta Pharma | $0.33 | -$0.77 | -$0.71 | 7.79% | $44.37M | $27.89M | $18.65M | -33.12% | 08/04/2020 | Get Alert |
| ENTA | Enanta Pharma | $0.20 | -$0.87 | -$0.30 | 65.52% | $39.63M | $27.64M | $27.62M | -0.08% | 05/06/2020 | Get Alert |
| ENTA | Enanta Pharma | $1.25 | $0.58 | $0.65 | 12.07% | $69.89M | $58.86M | $52.57M | -10.69% | 02/06/2020 | Get Alert |
| ENTA | Enanta Pharma | $1.30 | $0.53 | $0.44 | -16.98% | $67.20M | $55.94M | $51.31M | -8.27% | 11/21/2019 | Get Alert |
| ENTA | Enanta Pharma | $0.97 | $0.16 | $0.33 | 106.25% | $57.26M | $46.98M | $44.37M | -5.56% | 08/06/2019 | Get Alert |
Enanta Pharma (ENTA) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Mar 2024 | 2024-05-06 | $-1.47 | $-1.33 | -10.5 % |
| Dec 2023 | 2024-02-07 | $-1.58 | $-1.19 | -32.8 % |
| Sep 2023 | 2023-11-20 | $-1.33 | $-2.00 | 33.5 % |
| Jun 2023 | 2023-08-07 | $-1.86 | $-2.33 | 20.2 % |
Enanta Pharma (ENTA) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Mar 2024 | 2024-05-06 | $17.05M | $16.52M | 3.23 % |
| Dec 2023 | 2024-02-07 | $18.00M | $21.28M | -15.4 % |
| Sep 2023 | 2023-11-20 | $18.93M | $17.50M | 8.20 % |
| Jun 2023 | 2023-08-07 | $18.89M | $18.06M | 4.61 % |
FAQ
When is Enanta Pharma (NASDAQ:ENTA) reporting earnings?
Enanta Pharma (ENTA) is scheduled to report earnings on August 5, 2024. The last reported earnings were for reported on May 6, 2024 for Q2.
What were the latest earnings per share (EPS) for Enanta Pharma (NASDAQ:ENTA)?
The Actual EPS was $-1.47, which missed the estimate of $-1.33.
What were Enanta Pharma’s (NASDAQ:ENTA) revenues?
The Actual Revenue was $17.1M, which beat the estimate of $16.5M.
Browse earnings estimates, EPS, and revenue on all stocks.